For example, no correlation of the PTEN status with the responsiveness of breast cancer cells towards GDC 0941 was detected [26] and neither p110 nor PTEN mutations were correlated with PI3K inhibitor sensitivity in the JFCR39 human cancer cell line panel [33]. Here, PTEN is linked to breast carcinoma.